Article
Prevalence of EGFR Mutations in Patients With Resected Stages I to III NSCLC: Results From the EARLY-EGFR Study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Oct 2024
Soo Ross A, Reungwetwattana Thanyanan, Perroud Herman Andres, Batra Ullas, Kilickap Saadettin, Tejado Gallegos Luis Fernando, Donner Natalia, Alsayed Mohamed, Huggenberger Reto, Van Tu Dao
Abstract excerpt
INTRODUCTION: There is limited literature on the prevalence of EGFR mutations in early stage NSCLC. EARLY-EGFR (NCT04742192), a cross-sectional study, determined the prevalence of EGFR mutations in early stage NSCLC. METHODS: This noninterventional, real-world study enrolled consecutive patients with resected stages IA to IIIB (American Joint Committee on Cancer eighth edition) NSCLC from 14 countries across...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.